Barkat Health & Pharmaceutical Group: In recent decades, Iran’s pharmaceutical industry has made significant progress despite challenges such as international sanctions and economic restrictions. The growth of knowledge-based companies, efforts towards self-sufficiency in drug production, and collaboration with international research centers indicate a positive trend in this sector.
However, with the emergence of new technologies globally, the industry requires further transformations to solidify its position in international competition. In recent years, innovative technologies such as drug delivery nanoparticles, biotechnology, artificial intelligence, genome editing, 3D printing, and personalized medicine have entered the global pharmaceutical arena, and these technologies are expected to gain traction in Iran soon.
In this context, this article explores the technologies that could transform Iran’s pharmaceutical industry.
Drug Delivery Nanoparticles
One of the most significant and advanced technologies influencing Iran’s pharmaceutical industry is drug delivery nanoparticles. This technology enables more precise and controlled delivery of drugs to specific areas of the body, helping to reduce the side effects of medications.
Nanoparticles are made from materials designed at the nanoscale and can deliver drugs in a controlled and targeted manner to diseased cells. This technology is particularly effective in treating cancer, cardiovascular diseases, and infections, as it can directly target diseased cells while minimizing impact on healthy ones.
Currently, several Iranian knowledge-based companies are active in the field of drug delivery nanoparticles. One successful example of this technology in Iran is the development of lipid nanoparticles for drug delivery to cancer cells, which is underway at various academic research centers. These projects may soon reach mass production, providing patients with more effective and cost-efficient medications.
Biotechnology
Biotechnology, which involves producing drugs using living organisms or biological systems, is another leading technology in the global pharmaceutical industry. Biologic drugs, such as monoclonal antibodies, hormones, and vaccines, are produced using this technology.
In Iran, biotechnology is rapidly expanding, with several pharmaceutical companies engaged in the production of biologic drugs. In the coming years, this technology is expected to become one of the main pillars of Iran’s pharmaceutical industry through international collaborations and the development of research infrastructure.
For instance, Iranian companies such as Sinogen and Pooyesh Darou are currently active in producing biopharmaceuticals, creating products like monoclonal antibodies for the treatment of autoimmune diseases and cancer. These companies have successfully exported their products to global markets through international collaborations.
Artificial Intelligence & Machine Learning
Another innovative technology that will impact Iran’s pharmaceutical industry is artificial intelligence (AI). AI assists researchers in accelerating the drug discovery process and identifying new pathways for developing more effective medications through the analysis of large and complex datasets.
AI can play a role in various areas of pharmaceuticals, including the discovery of new drug molecules, predicting drug side effects, and improving production and distribution processes. Additionally, machine learning can aid in the development of personalized medications tailored to the genetic and physiological characteristics of each patient.
In Iran, some knowledge-based companies are working on AI projects in pharmaceuticals. One of these projects involves using machine learning algorithms to predict drug side effects during
laboratory stages. This technology helps improve research efficiency and reduces the time required for new drugs to enter the market.
3D Printing of Drugs
3D printing is revolutionizing pharmaceutical manufacturing approaches. This technology enables the production of complex medications with high precision tailored to each patient’s needs. It supports the creation of personalized medicines and is particularly effective in drug delivery for specific patients or those requiring precise dosages. In the near future, 3D printing of drugs may also become widespread in Iran, improving treatment quality for patients with specific conditions.
Efforts are underway in some research centers in Iran to utilize 3D printing technology in the production of multilayer tablets. These tablets can combine multiple medications into a single pill and regulate the release of drugs in a controlled manner.
Genome Editing
Genome editing is one of the most revolutionary technologies that could impact the future of the pharmaceutical and treatment industry. Using tools like CRISPR-Cas9, it is possible to accurately correct defective genes in human cells, offering new treatments for genetic disorders, cancer, and neurological diseases.
In Iran, projects are ongoing to utilize CRISPR genome editing technology. These projects are primarily focused in universities and research centers, aiming to develop new treatments for conditions such as thalassemia and certain genetic cancers.
Challenges of New Technologies into Pharmaceutical Industry
The introduction of new technologies to any industry faces unique challenges. In Iran’s pharmaceutical industry, this issue is clearly evident. Some of the significant challenges include:
- Sanctions and International Restrictions: The economic and scientific sanctions imposed against Iran have significantly impacted the supply chain for raw materials, laboratory equipment, and access to international knowledge. The introduction of technologies such as AI, genome editing, and drug delivery nanoparticles requires extensive international collaborations, which these sanctions can create serious obstacles to.
- Lack of Research and Educational Infrastructure: A major problem for developing and implementing new technologies in Iran is the lack of up-to-date research and laboratory infrastructure. The development of these technologies requires modern, equipped laboratories and specialized human resources, which are insufficient in some cases within the country.
- Insufficient Investment in Research and Development: To succeed in implementing new technologies such as 3D drug printing or biotechnology, serious investment in research and development is necessary. Many pharmaceutical companies are unable to invest in these areas due to a lack of sufficient financial resources.
- Resistance to Change*: The traditional pharmaceutical industry in Iran is slow to respond to new technologies due to strict regulations and outdated structures. This resistance may exist at the policy level, among manufacturers, and even among some professionals in the pharmaceutical field.
Opportunities for Developing New Technologies
Despite the challenges, Iran possesses suitable opportunities for implementing and developing new technologies in the pharmaceutical industry. The increasing number of knowledge-based companies in pharmaceuticals and biotechnology is one of the most important opportunities for introducing innovative technologies. These companies, leveraging a young, specialized workforce and internal scientific resources, can play a crucial role in the development and production of nanoparticle-based drugs, personalized medicines, and biopharmaceuticals.
Despite sanctions, Iran has been able to collaborate with allied countries in scientific and pharmaceutical fields. Countries like China, Russia, and some regional countries are key partners for Iran in pharmaceutical and innovative technology projects. These collaborations can be particularly strengthened in the fields of biotechnology and vaccine production.
The large population of Iran and the significant demand for new medications create substantial opportunities for companies active in pharmaceutical technologies. The domestic market can serve as a suitable platform for testing and developing technologies such as 3D printing of drugs or artificial intelligence in drug discovery.
Role of the Government and Supportive Policies
The Iranian government plays a vital role in developing new technologies in the pharmaceutical industry. Government support policies for knowledge-based companies and drug manufacturers can significantly influence the introduction and expansion of these technologies.
The government can assist knowledge-based companies and universities by increasing research and development budgets, enabling them to explore innovative technologies like genome editing and drug delivery nanoparticles. Establishing joint research and production projects with countries possessing advanced technologies can help transfer knowledge and technology to Iran.
Government support for such collaborations, especially in advanced drug and vaccine production, is crucial. By reforming strict regulations and encouraging innovation, the government can create a more conducive environment for the introduction of new technologies.
For example, streamlining the approval process for new drugs and innovative technologies could enhance innovation and competition in the pharmaceutical industry.
Conclusion
Despite numerous challenges, Iran’s pharmaceutical industry is rapidly advancing, and innovative technologies developed globally will soon enter this sector. Drug delivery nanoparticles, biotechnology, artificial intelligence, 3D drug printing, and genome editing are just some of the technologies that will transform the future of Iran’s pharmaceutical landscape.
These technologies will not only improve treatment quality but also create new opportunities for developing new drugs and reducing costs. By investing in research infrastructure and strengthening international collaborations, Iran can become a regional leader in innovative pharmaceutical technologies.
Innovative technologies such as drug delivery nanoparticles, biotechnology, artificial intelligence, 3D drug printing, and genome editing will reshape the future of Iran’s pharmaceutical industry. These technologies can enhance the quality and efficacy of treatments and help Iran gain a special position in international pharmaceutical markets.
However, success in implementing these technologies requires addressing existing challenges, strengthening research infrastructure, and providing government support for the pharmaceutical industry.
Given the existing opportunities and potentials, Iran can become one of the regional pioneers in the field of innovative pharmaceutical technologies. Investment in education, research and development, and collaboration with advanced countries in this area is key to achieving this goal.
برای امتیاز به این نوشته کلیک کنید!
